Meet four scientists contributing to the malaria elimination agenda and the future of African research through their work. Each of these scientists are also scholarship recipients from the EDCTP2-funded SINDOFO and PAMAfrica consortia.
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
The Lancet infectious diseases
Peer reviewed article